Welcome to our dedicated page for Broadridge Finl Solutions SEC filings (Ticker: BR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Broadridge Financial Solutions filings document a NYSE-listed financial technology company with common stock registered under the Exchange Act. The company’s Form 8-K disclosures cover operating and financial results, Regulation FD investor presentations, dividend declarations, board composition changes, annual meeting voting results, and other material events.
Broadridge’s regulatory record also includes capital-structure and securities disclosures tied to its public equity and debt activity, along with governance matters such as director elections, executive compensation votes, auditor ratification, committee assignments, and risk-factor language accompanying investor materials and earnings releases.
Broadridge Financial Solutions CEO reports charitable stock gift
The CEO of Broadridge Financial Solutions reported a disposition of 5,709 shares of common stock on 12/05/2025, coded as a bona fide charitable gift at a price of $0.0000. After this transaction, the reporting person beneficially owns 137,576.0271 shares of Broadridge common stock in direct ownership. The filing indicates this was a voluntary transfer for charitable purposes rather than an open-market sale.
Broadridge Financial Solutions, Inc. insider stock activity: A corporate vice president reported multiple option exercises and share sales in Broadridge Financial Solutions, Inc. common stock. On 12/03/2025, the officer exercised stock options for 6,000 shares at an exercise price of $148.07 and 4,163 shares at an exercise price of $93.88. The same day, the officer sold 1,150, 3,516 and 5,548 shares of common stock at a weighted average price of $229.2557 per share, with the actual sale prices ranging from $228.89 to $229.71. Following these transactions, the officer directly beneficially owns 6,026 shares of Broadridge common stock and 8,548 stock options.
An affiliate of the issuer filed a Form 144 notice to sell 10,214 shares of common stock through Morgan Stanley Smith Barney LLC on or about 12/03/2025 on the NYSE. The filing lists an aggregate market value of $2,341,617.72 for the planned sale and notes that 116,727,559 shares of this class were outstanding.
The securities to be sold were acquired through restricted stock vesting and stock option exercises under registered plans. These include 1,150 shares from restricted stock vesting on 11/11/2024 and option exercises for 3,516 and 5,548 shares on 12/03/2025, with the option exercises paid in cash. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.
BR reported a planned sale of restricted stock under Rule 144. A holder intends to sell 3984 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 900384. The shares were acquired on 04/01/2025 through restricted stock vesting under a registered plan from the issuer. The notice lists 116727559 shares of the issuer’s common stock outstanding, providing context for the relative size of this planned sale.
BR reported a planned sale of restricted stock under Rule 144. A holder intends to sell 3984 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 900384. The shares were acquired on 04/01/2025 through restricted stock vesting under a registered plan from the issuer. The notice lists 116727559 shares of the issuer’s common stock outstanding, providing context for the relative size of this planned sale.
Broadridge Financial Solutions (BR) reported an insider stock sale by a company officer who serves as President. On 11/18/2025, the officer sold 3,984 shares of Broadridge common stock in an open market transaction coded "S" at a price of $226 per share. After this transaction, the officer continued to beneficially own 44,828.521 shares of Broadridge common stock, held in direct ownership. This filing reflects a routine Form 4 disclosure of insider trading activity by a single reporting person.
Broadridge Financial Solutions (BR) reported an insider stock sale by a company officer who serves as President. On 11/18/2025, the officer sold 3,984 shares of Broadridge common stock in an open market transaction coded "S" at a price of $226 per share. After this transaction, the officer continued to beneficially own 44,828.521 shares of Broadridge common stock, held in direct ownership. This filing reflects a routine Form 4 disclosure of insider trading activity by a single reporting person.
Broadridge Financial Solutions (BR) director reported receiving 459 shares of common stock on 11/13/2025 as a Deferred Stock Unit grant under Broadridge's 2018 Omnibus Award Plan.
The filing also reports a stock option grant for 1,758 shares at an exercise price of $225.61, vesting immediately and expiring on 11/13/2035. After the stock grant, the director beneficially owned 8,343 common shares held directly. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock when the director separates from service.
Broadridge Financial Solutions (BR) reported a routine equity award to one of its directors. On 11/13/2025, the director received 459 shares of common stock at a price of $0.0000, increasing the director’s directly held stake to 8,987 shares. The director was also granted a stock option for 1,758 shares with an exercise price of $225.61, exercisable from 11/13/2025 and expiring on 11/13/2035. The stock grant reflects Deferred Stock Units issued under Broadridge’s 2018 Omnibus Award Plan, which vest immediately and will be settled in shares when the director leaves board service, while the stock options also vest immediately upon grant.
Broadridge Financial Solutions, Inc. (BR) reported a routine director equity award on a Form 4. On 11/13/2025, a director received 831 Deferred Stock Units of Broadridge common stock at $0.0000 per unit, increasing the director’s directly held common stock to 4,543 shares after the transaction. The director was also granted a stock option for 3,182 shares with an exercise price of $225.61 per share, vesting immediately and expiring on 11/13/2035. The Deferred Stock Units vest in full upon grant and will be settled in shares when the director separates from service with Broadridge.
Broadridge Financial Solutions, Inc. (BR) reported equity awards for one of its directors. On 11/13/2025, the director received 459 Deferred Stock Units of Broadridge common stock at a stated price of $0.0000, increasing the director’s directly held common stock to 31,780.102 shares. These Deferred Stock Units vest in full upon grant and will be settled in shares of common stock when the director leaves service.
On the same date, the director was also granted a stock option covering 1,758 shares of Broadridge common stock with an exercise price of $225.61 per share. The option vests immediately and is exercisable from 11/13/2025 until its expiration on 11/13/2035. Both awards are made under Broadridge’s 2018 Omnibus Award Plan and reflect standard equity-based director compensation.
Broadridge Financial Solutions (BR) reported an equity award to one of its directors. On 11/13/2025, the director received 459 Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, representing the same number of shares of common stock. These units vest in full upon grant and will be settled in shares of Broadridge common stock when the director separates from service. The filing also shows a grant of 1,758 stock options with an exercise price of $225.61 per share, which vest immediately and expire on 11/13/2035. Following the stock unit grant, the director directly owns 2,649 shares of Broadridge common stock, in addition to the stock options.